Curie.Bio logo

Curie.Bio

North America, Massachusetts, United States, Boston

Description

Curie.Bio is a founder-focused seed-stage venture capital firm.

Investor Profile

Curie.Bio has made 9 investments, with 2 in the past 12 months and 56% as lead.

Stage Focus

  • Seed (56%)
  • Series B (33%)
  • Series Unknown (11%)

Country Focus

  • United States (89%)
  • Australia (11%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Emergency Medicine
  • Genetics
  • Precision Medicine
  • Alternative Medicine
  • Fitness
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Curie.Bio frequently co-invest with?

Johnson & Johnson Innovation – JJDC
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Bristol-Myers Squibb
North America, New York, United States, New York
Co-Investments: 1
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 3
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 2
Third Rock Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 2
Casdin Capital
North America, New York, United States, New York
Co-Investments: 3
AV
South America, Sao Paulo, Brazil, São Paulo
Co-Investments: 1
ArchVentures SA
Europe, Faro, Portugal, Faro
Co-Investments: 1
Andreessen Horowitz
North America, California, United States, Menlo Park
Co-Investments: 1
Section 32
North America, California, United States, San Diego
Co-Investments: 3

What are some of recent deals done by Curie.Bio?

Alkira Bio

Melbourne, Victoria, Australia

Alkira Bio enables the discovery of next-generation therapeutic antibodies that target complex membrane proteins.

BiotechnologyTherapeutics
SeedJul 4, 2024
Tesseract Medical Research

Napa, California, United States

Tesseract Medical Research is a biotechnology and medical sciences business focused on delivering nutrition to meet unmet needs.

Alternative MedicineBiotechnologyFitnessHealth CareWellness
SeedJun 11, 2024
Amount Raised: $20,000,000
ROME Therapeutics

Cambridge, Massachusetts, United States

ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.

BiotechnologyHealth CarePharmaceutical
Series BSep 12, 2023
Amount Raised: $72,000,000
Thrive Earlier Detection

Cambridge, Massachusetts, United States

Thrive Earlier Detection is a healthcare company that integrates earlier cancer detection into routine medical care.

BiotechnologyHealth CareHealth DiagnosticsMedical
Series UnknownJan 1, 2023
Astoria Biologica, Inc.

Jupiter, Florida, United States

Astoria Biologica is developing novel therapies for multiple sclerosis

BiotechnologyHealth CareMedicalTherapeutics
SeedDec 1, 2022
Decrypt Biomedicine

New York, New York, United States

Decrypt Biomedicine develops small-molecule drugs targeting cryptic binding sites on proteins.

Biotechnology
SeedDec 1, 2022
Differentiated Therapeutics

Boston, Massachusetts, United States

Differentiated Therapeutics is to design and develop disease-modifying TPD therapies for patients with unmet medical need.

BiotechnologyPharmaceuticalTherapeutics
SeedAug 1, 2022
Amount Raised: $5,000,000
MOMA Therapeutics

Cambridge, Massachusetts, United States

MOMA Therapeutics operates as a biotechnology company.

BiotechnologyMedicalTherapeutics
Series BMay 10, 2022
Amount Raised: $150,000,000
Celsius Therapeutics

Cambridge, Massachusetts, United States

Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.

BiotechnologyEmergency MedicineGeneticsHealth CarePrecision Medicine
Series BMar 24, 2022
Amount Raised: $83,000,000